Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Teucrium marum is a homeopathic medicine derived from the plant *Teucrium marum* L., commonly known as cat thyme, an evergreen shrub native to Spain and the Western Mediterranean. The preparation is manufactured according to the Homeopathic Pharmacopoeia of the United States (HPUS) standards and is typically sold as oral pellets or tablets in various dilutions (e.g., 1X, 30C, 200CK). It is primarily indicated in homeopathic practice for the relief of anal pruritus (itching of the anus). Historically, it has also been used to treat respiratory conditions such as spasmodic asthma, as well as mucosal polyps of the nose and ears. Major manufacturers and marketers of this remedy include Boiron and Rxhomeo. As a homeopathic product, it does not have a recognized conventional pharmacological mechanism of action or specific molecular targets, and its efficacy has not been evaluated by the FDA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on teucrium marum.